GP KFPs / SAQs · gastrointestinal-health
Bowel cancer screening — KFP-style written assessment
KFP-style staged scenarios on bowel cancer screening: managing the positive kit, the symptomatic patient who must never enter the screening pathway, colonoscopy quality as a survival variable, follow-up after the scope, and lifting participation in the practice population.
On this page
Study tools
Target exams
RACGP KFPRACGP AKTMRCGP AKT
Prompt
Bowel cancer screening: every positive is a colonoscopy, symptoms choose their own pathway, and quality at the scope decides who gets an interval cancer
KFP 1 (10 marks)
A 64-year-old man's National Bowel Cancer Screening Program kit returns positive. His wife phones, alarmed. When he attends, he says he feels completely well and asks whether "the test might have got it wrong". He has no bowel symptoms, no family history, takes ibuprofen occasionally for knees. [15]
- What does the positive result mean numerically, and what single action follows? (3) [15]
- How do you answer "might it have got it wrong"? (4) [15]
- He asks what happens if the colonoscopy finds nothing. (3) [10]
Model answers
- A positive immunochemical FOBT means blood in the stool that he cannot see, detected at the programme threshold. The numbers: in 2024, 73,745 Australians returned positive kits (5.8% positivity), and among those with a recorded diagnostic assessment, 1 in 29 had confirmed or suspected cancer and 1 in 3 had an adenoma. One action follows — colonoscopy, arranged through the appropriate referral pathway without delay; median programme time from positive result to assessment is 62 days and his practice should beat that. [15]
- Yes, false positives occur — that is inherent to any screening test chosen to catch many cancers. But the response to uncertainty is not repetition: repeating the kit delays diagnosis of exactly the lesions being hunted, and a negative repeat would not exclude them. The trade has been made deliberately: accept roughly one colonoscopy per three adenomas and one per 29 cancers found. Ibuprofen can cause occult bleeding — mention it to the endoscopist, but it neither cancels nor downgrades the investigation. [15]
- Then the positive has been explained or outgrown, and he returns to two-yearly population screening — a normal colonoscopy after a positive FIT carries no special surveillance. The episode closes with a documented plan and a date for the next kit, not with discharge into silence. [10]
References10ShowHide
- [1]Hewitson P, Glasziou P, Watson E, Towler B, Irwig L Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. American Journal of Gastroenterology, 2008.PMID 18479499
- [2]Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. New England Journal of Medicine, 2014.PMID 24693890
- [5]Jensen CD, Corley DA, Quinn VP, et al. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection. Annals of Internal Medicine, 2018.PMID 30242328
- [10]Chang WK, Kim KO, Cheung DY, et al. Strategies to improve screening colonoscopy quality for the prevention of colorectal cancer. Korean Journal of Internal Medicine, 2024.PMID 38247125
- [11]Anonymous Risk of colonoscopy-related complications in a fecal immunochemical test-based population colorectal cancer screening program. Endoscopy, 2022.PMID 33271603
- [12]Anonymous Characteristics of Interval Colorectal Cancer: A Canadian Retrospective Population-Level Analysis from Newfoundland and Labrador. Current Oncology, 2022.PMID 36547130
- [15]Anonymous Interval Cancer Characteristics, Staging and Survival Among National Bowel Cancer Screening Program Participants, Western Australia. Medical Journal of Australia, 2026.PMID 41629194
- [14]Anonymous Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome. Annals of Surgical Oncology, 2017.PMID 27766559
- [8]Perry N et al. Optimising SMS content for bowel cancer screening participation in Australia: cross-sectional national survey findings. Public Health Res Pract, 2026.PMID 42112944
- [9]Lofti-Jam KL et al. Increasing bowel cancer screening participation: integrating population-wide, primary care and more targeted approaches. Public Health Res Pract, 2019.PMID 31384890